Lo sentimos, la página que usted busca no se ha podido encontrar. Puede intentar su búsqueda de nuevo o visitar la lista de temas populares.

Event

Bipolar Disorder: Making the Diagnosis

Wednesday, August 29, 2018 · 9:00 am - 10:30 am

Dr. Vivian Kafantaris is a nationally recognized expert in the treatment of children and adolescents with bipolar disorder. She and her team have designed and completed several NIH-funded randomized controlled treatment trials in children and adolescents with bipolar disorder and attention-deficit hyperactivity disorder.

Dr. Kafantaris has a longstanding interest in developing evidence-based treatments for children and adolescents with severe psychiatric illnesses. She has more than 20 years of experience in the conduct of clinical trials in children and adolescents and has published extensively on the use of lithium in adolescents with bipolar disorder and the efficacy of other mood stabilizers for the treatment of non-bipolar aggression.

CME Accreditation:

Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

Northwell Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 credits ™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy:

Northwell Health adheres to the ACCME’s Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with commercial interests. All relevant conflicts of interest will be resolved prior to the commencement of the activity.

Planner and Speaker’s Disclosures: 

Harold Koplewicz, MD, Ron Steingard, MD, and John Q. Young, MD, have nothing to disclose. Vivian Kafantaris, MD, has nothing to disclose.

Recognition of Program Support:

An announcement of program support will be made to all attendees at the beginning of each Regularly Scheduled Session.